期刊文献+

复方利多卡因乳膏联合普瑞巴林治疗带状疱疹后神经痛35例临床观察 被引量:25

Clinical observation of compound lidocaine cream combined with pregabalin in the treatment of postherpetic neuralgia:a study of 35 cases
下载PDF
导出
摘要 目的观察复方利多卡因乳膏联合普瑞巴林治疗带状疱疹后神经痛(PHN)的疗效。方法2015年12月至2017年12月荆州市第一人民医院69例PHN病人用随机数字表法分为试验组(35例)和对照组(34例)。试验组:普瑞巴林150 mg,2次/天口服,联合应用复方利多卡因乳膏外擦患处,2次/天;对照组:单独应用口服普瑞巴林150 mg,2次/天口服。两组均分别治疗8周。记录两组病人治疗前及治疗后2、4、6、8周时的疼痛评分[视觉模拟评分法(VAS)],治疗前及治疗8周后睡眠状况、生活质量及不良反应发生情况。结果由于失访5例,因严重不良反应退出4例,最终标本总数60例,两组各30例。治疗前试验组、对照组的VAS评分为(7.03±1.21)分、(7.06±1.56)分,治疗2周后降至(4.03±1.35)分、(6.13±1.48)分,组间比较差异也有统计学意义(t=5.742,P=0.000),治疗后4、6、8周亦存在相似情况。治疗8周后睡眠状况及生活质量均得到改善,且试验组改善程度明显优于对照组,差异有统计学意义(t=15.208、21.893,均P=0.000),两组不良反应主要为头晕、嗜睡,差异无统计学意义(P>0.05)。结论复方利多卡因乳膏联合普瑞巴林对PHN病人的临床效果优于单独应用普瑞巴林。 Objective To observe the effect of compound lidocaine cream combined with pregabalin on postherpetic neuralgia(PHN).Methods Sixty⁃ninepatients with PHN treated in the Fist Hospital of Jingzhou City from December 2015 to December 2017 were divided into experimental group(35 patients)and control group(34 patients)randomly.Experimental group was treated with pregabalin 150 mg orally twice a day,combined with the use of compound lidocaine cream on the skin area of pain twice a day.Control group was treated with pregabalin 150 mg orally twice a day.Both groups were treated for 8 weeks.The analgesic effect(visual analogue scale,VAS)before and 2,4,6,8 weeks after treatment,and sleep status,quality of life,adverse reactions before and 8 weeks after treatment were recorded in both groups.Results There were 5 patients of lost follow⁃up and 4 patients of withdrawal due to serious adverse reactions.The total number of final samples was 60,with 30 cases in each group.Before treatment,the VAS scores of the experimental group and the control group were(7.03±1.21)and(7.06±1.56),which decreased to(4.03±1.35)and(6.13±1.48)after 2 weeks of treatment.There were statistically significant differences between the two groups(t=5.742,P=0.000).Similar situations also existed in 4,6 and 8 weeks after treatment.After 8 weeks of treatment,the sleep status and quality of life were improved,and the improvement degree of the experimental group was significantly better than that of the control group,the difference was statistically significant(t=15.208,21.893,both P=0.000).The adverse reactions of the two groups were mainly dizziness and lethargy,the difference was not statistically significant(P>0.05).Conclusion The clinical effect of compound lido⁃caine cream combined with pregabalin on PHN patients was better than that of pregabalin alone.
作者 龚少智 黄发清 鲁昌宇 杨家彬 龚锦 GONG Shaozhi;HUANG Faqing;LU Changyu;YANG Jiabin;GONG Jin(Dermatology Department,The Fist Hospital of Jingzhou City,Jingzhou,Hubei 434000,China)
出处 《安徽医药》 CAS 2020年第3期597-599,共3页 Anhui Medical and Pharmaceutical Journal
关键词 神经痛 带状疱疹后 利多卡因 普瑞巴林 软膏 治疗结果 老年人 Neuralgia,postherpetic Lidocaine Pregabalin Ointments Treatment outcome Aged
  • 相关文献

参考文献2

二级参考文献20

  • 1Norrbrink Budh C, Lund I, Ertzgaard P, et al. Pain in Swed- ish spinal cord injury population[J]. Clin Rehab, 2003,17(3): 685---690.
  • 2Tan T, Barry P, Reken S, et al. Pharmacological management of Neuropathicin non-specialist setting: summmary of NICE guidance[J]. BMJ, 2010, 340: c1079.
  • 3Defrin R, Ohry A, Blumen N, et at. Characterization of chron- ic pain and somatosensory function in spinal cord injury sub- jects[J]. Pain, 2001,89(3):253--263.
  • 4Cruz-Almeida Y, Martinez-Arizala A, Widerstro EG. Chronici- ty of pain associated with spinal cord injury: A longitudinal analysis[J]. J Rehabil Res Dev, 2005(4),42:585--594.
  • 5Kaley TJ, Deangelis LM. Therapy of chemotherapy-induced peripheral neuropathy[J]. Br J Haematol, 2009, 145(1):3--14.
  • 6Wang G, Thompson SM. Maladaptive homeostatic plasticity in a rodent model of central pain syndrome: thalamic hyper ex- citability after spinothalamic tract lesions[J]. J Neurosci,2008,28 (46): 11959---11969.
  • 7Richter RW, Portenoy R, Sharma U, et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo controlled trial[J]. Pain, 2005, 6 : 253--260.
  • 8Rose MA, Kam PC. Gabapentin: Pharmacology and its use in pain management[J]. Anesthesia, 2002, 57(5):451--462.
  • 9Wesche D, Bockbrader H. A pharmacokinetic comparison of pregabalin and gabapentin[J]. Pain, 2005, 6(3): $29.
  • 10Dubinsky RM, Kabbani H, EL-Chami Z, et al. Qulity Standards of the American Academy of neurology. Practice parameter: treatment of posttherpetic neuralgia: an evidence-based report of the Qulity Standards Subcom mittee of the American Academy of Neurology[J]. Neurology, 2004, 63(6): 959-965.

共引文献36

同被引文献211

引证文献25

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部